Paradigm Health

Paradigm Health is rebuilding the clinical research ecosystem by creating a platform that enables equitable access to trials for all patients. By integrating directly with healthcare provider organizations, the company combines technology and services to enhance trial efficiency and reduce barriers to participation. The platform connects patients, providers, and trial sponsors in a seamless infrastructure designed to bring life-saving therapies to patients faster.

Incubated by ARCH Venture Partners and backed by leading healthcare and life sciences investors, Paradigm Health focuses on orienting clinical trials around patient care. The company's mission-driven approach addresses critical challenges in clinical research, where drug development faces massive hurdles - 50% of drugs fail to meet enrollment targets, and the average cost to develop a new drug reaches $2 billion. Paradigm Health's intelligent research platform delivers proven outcomes, with partners like Highlands Oncology achieving 45% increases in clinical trial enrollment while reducing research department burden.